|
KMID : 0357920010350040278
|
|
Korean Journal of Pathology
2001 Volume.35 No. 4 p.278 ~ p.285
|
|
|
Immunophenotype of Thymic Epithelial Tumors According to the New World Health Organization Classification
|
|
Park Sung-Hye
Kim Han-Seong
Kim Han-Kyeom
Shin Bong-Kyung
Hong Seung-Mo
Ro Jae Y.
|
|
|
Abstract
|
|
|
Background: To identify the expression patterns and usefulness of various antibodies in making diagnoses and predicting prognoses, an immunohistochemical study was performed on thymic epithelial tumors (TETs).
Methods: Forty-two cases of TETs were reclassified according to the new World Health Organization (WHO) classifications. CD3, CD5, CD79a, CD99, pan-, high- and low-molecular weight cytokeratins, EMA, vimentin, MIB-1 (Ki67) and p53 immunostaining were carried out.
Results: There were two, twelve, eight, two, thirteen and one case for type A, AB, B1, B2, B3 and C, respectively. Combined B1/B2 and B2/B3 were 2 cases each. Fourteen cases (33.3%) had myasthenia gravis. CD99 was immunoreactive mainly in cortically derived lymphocytes, while CD3 and CD5 were immunoreactive in medullary-derived lymphocytes. CD5 immunoreactivity was negative in all thymic epithelial cells, except for one case of type B3. MIB-1 indices were highly expressed in cortical lymphocytes and some thymic epithelial cells, but did not show any correlation with grades. p53 in thymic epithelial cells was expressed in 6 (46%) out of 13 cases of type B3 and one case of type C, and it was negative in all other subtypes.
Conclusions: Only p53 was helpful for predicting high grades (B3 and C) (p<0.05). By MIB-1 indices, we could tell how many cortical immature lymphocytes were occupied in TETs, however, grading could not be achieved.
|
|
|
KEYWORD
|
|
|
Thymus gland, Neoplasms, Immunohistochemistry, World Health Organization, Histological classification
|
|
|
FullTexts / Linksout information
|
|
 
|
|
|
Listed journal information
|
|
  
|
|